The latest financial statement is for the quarter ending 2025-10-03.
| Cash Flow | 2025-10-03 | 2025-07-04 |
|---|---|---|
| Net income | 28,044 | 53,203 |
| Depreciation and amortization of property, equipment and leasehold improvements | 2,532 | 5,012 |
| Provision for contract losses and doubtful accounts | 1,511 | 586 |
| Stock-based compensation | 5,341 | 13,426 |
| Deferred income tax provision | -2,867 | -3,094 |
| Accounts receivable | 12,495 | 10,191 |
| Prepaid expenses and other current assets | 4,021 | -7,135 |
| Change in operating leases | -1,301 | -1,756 |
| Accounts payable and accrued liabilities | -189 | 4,153 |
| Accrued payroll and employee benefits | 12,246 | -23,774 |
| Deferred revenues | 1,249 | -4,716 |
| Net cash provided by operating activities | 32,652 | 43,496 |
| Capital expenditures | 2,675 | 4,028 |
| Net cash used in investing activities | -2,675 | -4,028 |
| Payroll taxes for restricted stock units | 0 | 4,166 |
| Repurchase of common stock | 40,032 | 32,680 |
| Exercise of stock-based payment awards | 595 | 911 |
| Dividends and dividend equivalents rights | 15,070 | 31,582 |
| Net cash used in financing activities | -54,507 | -67,517 |
| Effect of foreign currency exchange rates on cash and cash equivalents | 109 | 949 |
| Net change in cash and cash equivalents | -24,421 | -27,100 |
| Cash and cash equivalents at beginning of period | 258,901 | - |
| Cash and cash equivalents at end of period | 207,380 | - |
EXPONENT INC (EXPO)
EXPONENT INC (EXPO)